A study of cefotaxime versus netilmicin versus netilmicin and cefotaxime in serious infections.
Sen
R A
RA
Department of Microbiology, Hope Hospital, University of Manchester School of Medicine, Eccles Old Road, Salford M6 8HD, UK.
Keaney
M G
MG
Ganguli
L A
LA
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy*; D002439:Cefotaxime / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004342:Drug Hypersensitivity; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009428:Netilmicin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D009428:Netilmicin; D002439:Cefotaxime